Ticker archive · $INO

$INO Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $INO — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$INO – Inovio Receives FDA Accelerated Approval for VOCERYQ in Adult RRP

INOVIO PHARMACEUTICALS, INC.
· SEC_8K · All $INO
?? Positive AI Sentiment (+8.5 / 10)
  • FDA grants accelerated approval for VOCERYQ (sifuplasmid-gxfd / INO-3107) for adults with recurrent respiratory papillomatosis (RRP).
  • Confirmatory trial protocol to be aligned by mid-2027 to confirm clinical benefit.
  • Commercial availability targeted to begin following approval.